Schulz B, Doberne L, Greenfield M, Reaven G M
Exp Clin Endocrinol. 1983 Jan;81(1):49-58. doi: 10.1055/s-0029-1210206.
A 5-hour insulin clamp was performed in 7 normal subjects (N) and 6 type-II-diabetics. After a 10-min-priming insulin infusion, a constant infusion of 1.813 micrograms/m2 s.a./min was given to all subjects. Glycemia was kept at fasting levels by a variable glucose infusion. Under these conditions the amount of metabolized glucose (M) has been calculated and served as a measure of insulin-stimulated glucose disposal. M differed markedly between N (35.6 +/- 3.11 mumol glucose/kg b.w./min and diabetics (17.8 +/- 1.17 mumol glucose/kg b.w./min; p less than 0.01) indicating a diminished insulin sensitivity in the latter group. However, M increased slightly but significantly until the end of the study in both groups. Under fasting conditions the mean percent 125I-insulin specifically bound to 3.5 X 10(9) erythrocytes/ml at tracer concentrations was 12 +/- 1.2% and 8.9 +/- 0.9% in N and diabetics, respectively. During insulin infusion specific insulin binding decreased significantly in both groups by 34% and 41%. Thus, the downregulation of insulin binding was similar in both groups and was due to changes in receptor affinity. Assuming that insulin binding to red blood cells mimic that to target cells we conclude that the cause of reduced glucose utilization in type-II-diabetes lies mainly in changes of postreceptor events rather than in receptor binding.
对7名正常受试者(N)和6名II型糖尿病患者进行了为期5小时的胰岛素钳夹试验。在进行10分钟的胰岛素预输注后,向所有受试者持续输注1.813微克/平方米体表面积/分钟的胰岛素。通过可变葡萄糖输注将血糖维持在空腹水平。在这些条件下,计算代谢葡萄糖量(M),并将其作为胰岛素刺激的葡萄糖处置的指标。正常受试者组(M为35.6±3.11微摩尔葡萄糖/千克体重/分钟)与糖尿病患者组(M为17.8±1.17微摩尔葡萄糖/千克体重/分钟;p<0.01)之间的M值有显著差异,表明后一组胰岛素敏感性降低。然而,在两组中,M值在研究结束前均略有但显著增加。在空腹条件下,在示踪剂浓度下,与每毫升3.5×10⁹个红细胞特异性结合的¹²⁵I胰岛素的平均百分比在正常受试者组和糖尿病患者组中分别为12±1.2%和8.9±0.9%。在胰岛素输注期间,两组的特异性胰岛素结合均显著降低,分别降低了34%和41%。因此,两组中胰岛素结合的下调相似,且是由于受体亲和力的变化所致。假设胰岛素与红细胞的结合模拟了其与靶细胞的结合,我们得出结论,II型糖尿病中葡萄糖利用减少的原因主要在于受体后事件的变化,而非受体结合的变化。